Benzodiazepine Market Information, By Applications (anxiety, insomnia, agitation, seizures, muscle spasms, alcohol withdrawal symptoms), By time of action (Long acting, Short acting), - Forecast Till 2030
ID: MRFR/Pharma/1674-HCR | 85 Pages | Published By Rahul Gotadki on April 2023
1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 Global Benzodiazepine Market, by Application
5.1 Introduction
5.1.1 Anxiety
5.1.2 Insomnia
5.1.3 Agitation
5.1.4 Seizures
5.1.5 Muscle spasms
5.1.6 Alcohol withdrawal symptoms
5.1.7 Anaesthesia supplements
7 Global Benzodiazepine Market, by Time of Action
7.1 Introduction
7.1.1 Long acting
7.1.3 Short acting
8 Global Benzodiazepine Market, by Regions
8.1 Introduction
8.1.1 Americas
8.1.1.1 North America
8.1.1.2 South America
8.1.2 Europe
8.1.2.1 Germany
8.1.2.2 France
8.1.2.3 UK
8.1.2.4 Italy
8.1.2.5 Spain
8.1.2.6 Rest of Europe
8.1.3 Asia Pacific
8.1.3.1 Japan
8.1.3.2 China
8.1.3.3 India
8.1.3.4 Republic of Korea
8.1.3.5 Rest of Asia Pacific
8.1.4 Middle East & Africa
9 Company Landscape
9.1 Introduction
9.1.1 Mergers Acquisitions
9.1.2 Collaborations
9.1.3 Release/New Product Launches
9.1.4 Other (Expansion, Updates, Partnership)
10 Company Profile
10.1 AstraZeneca plc
10.1.1 Company Overview
10.1.2 Product/Business Segment Overview
10.1.3 Financials
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Eli Lilly and Company
10.2.1 Overview
10.2.2 Product/Business Segment Overview
10.2.3 Financials
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 GlaxoSmithKline plc
10.3.1 Overview
10.3.2 Product/Business Segment Overview
10.3.3 Financials
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.4 Pfizer, Inc.
10.4.1 Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financials
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.5 Sanofi S.A.
10.5.1 Overview
10.5.2 Product/Business Segment Overview
10.5.3 Financials
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Merck & Co., Inc.
10.6.1 Overview
10.6.2 Product/Business Segment Overview
10.6.3 Financials
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Others
11 Appendix
List of Tables
TABLE 1 GLOBAL BENZODIAZEPINE MARKET, 2020-2027 (USD MILLION)
TABLE 2 GLOBAL BENZODIAZEPINE MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL BENZODIAZEPINE MARKET, BY TIME OF ACTION, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL BENZODIAZEPINE MARKET, BY REGION, 2020-2027 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL BENZODIAZEPINE MARKET, BY APPLICATION
FIGURE 4 GLOBAL BENZODIAZEPINE MARKET, BY TIME OF ACTION
FIGURE 5 GLOBAL BENZODIAZEPINE MARKET, BY REGION
FIGURE 6 GLOBAL BENZODIAZEPINE MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
